Adaptimmune Therapeutics PLC (ADAP)
1.11
-0.06
(-5.13%)
USD |
NASDAQ |
May 26, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
Adaptimmune Therapeutics Price: 1.11 for May 26, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 26, 2023 | 1.21 | 1.21 | 1.05 | 1.11 | 1.436M |
| May 25, 2023 | 1.21 | 1.23 | 1.11 | 1.17 | 1.013M |
| May 24, 2023 | 1.23 | 1.24 | 1.15 | 1.20 | 1.045M |
| May 23, 2023 | 1.28 | 1.315 | 1.20 | 1.22 | 658073.0 |
| May 22, 2023 | 1.32 | 1.33 | 1.27 | 1.28 | 447343.0 |
| May 19, 2023 | 1.32 | 1.34 | 1.30 | 1.31 | 338993.0 |
| May 18, 2023 | 1.33 | 1.38 | 1.28 | 1.31 | 496061.0 |
| May 17, 2023 | 1.32 | 1.38 | 1.27 | 1.34 | 582993.0 |
| May 16, 2023 | 1.36 | 1.37 | 1.31 | 1.31 | 475297.0 |
| May 15, 2023 | 1.37 | 1.43 | 1.36 | 1.39 | 544316.0 |
| May 12, 2023 | 1.42 | 1.42 | 1.35 | 1.37 | 418356.0 |
| May 11, 2023 | 1.41 | 1.41 | 1.35 | 1.36 | 266266.0 |
| May 10, 2023 | 1.40 | 1.44 | 1.37 | 1.40 | 257601.0 |
| May 09, 2023 | 1.40 | 1.42 | 1.36 | 1.40 | 140938.0 |
| May 08, 2023 | 1.42 | 1.45 | 1.37 | 1.40 | 1.165M |
| May 05, 2023 | 1.40 | 1.42 | 1.37 | 1.40 | 459221.0 |
| May 04, 2023 | 1.42 | 1.42 | 1.36 | 1.39 | 230992.0 |
| May 03, 2023 | 1.36 | 1.46 | 1.352 | 1.40 | 1.988M |
| May 02, 2023 | 1.40 | 1.43 | 1.36 | 1.37 | 350562.0 |
| May 01, 2023 | 1.40 | 1.465 | 1.40 | 1.43 | 652695.0 |
| Apr 28, 2023 | 1.39 | 1.43 | 1.33 | 1.42 | 401510.0 |
| Apr 27, 2023 | 1.36 | 1.41 | 1.36 | 1.36 | 1.218M |
| Apr 26, 2023 | 1.32 | 1.39 | 1.32 | 1.36 | 377274.0 |
| Apr 25, 2023 | 1.36 | 1.38 | 1.29 | 1.32 | 655819.0 |
| Apr 24, 2023 | 1.35 | 1.44 | 1.33 | 1.38 | 818331.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.725
Minimum
Nov 15 2019
14.16
Maximum
Oct 04 2018
4.417
Average
3.95
Median
Jun 10 2019
Price Benchmarks
| Akari Therapeutics PLC | 0.1851 |
| NuCana PLC | 0.85 |
| Mereo BioPharma Group PLC | 1.07 |
| DBV Technologies SA | 1.85 |
| Verona Pharma PLC | 21.39 |
Price Related Metrics
| PS Ratio | 2.553 |
| Price to Book Value | 2.193 |
| Earnings Yield | -64.30% |
| Market Cap | 183.93M |